Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offer of Its 6.125% Senior Subordinated Notes due 2014 for Registere
June 01 2005 - 9:00AM
PR Newswire (US)
Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offer
of Its 6.125% Senior Subordinated Notes due 2014 for Registered
Notes HERCULES, Calif., June 1 /PRNewswire-FirstCall/ -- Bio-Rad
Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer
and distributor of life science research products and clinical
diagnostics, announced today that it has completed its offer to
exchange (the "Exchange Offer") up to $200 million aggregate
principal amount of its 6.125% Senior Subordinated Notes due 2014
which have been registered under the Securities Act of 1933, as
amended for any and all of its outstanding 6.125% Senior
Subordinated Notes due 2014 which were issued in a private
placement (the "Private Notes"). All of the $200 million aggregate
principal amount of the Private Notes were tendered and received
prior to expiration of the Exchange Offer at 5:00 p.m., New York
City time, on May 31, 2005. This announcement is not an offer to
exchange, or a solicitation of an offer to exchange, with respect
to the Private Notes. The Exchange Offer was made solely by the
prospectus dated May 2, 2005. Bio-Rad Laboratories, Inc.
(http://www.bio-rad.com/) is a multinational manufacturer and
distributor of life science research products and clinical
diagnostics. It is based in Hercules, California, and serves more
than 70,000 research and industry customers worldwide through a
network of more than 30 wholly owned subsidiary offices.
DATASOURCE: Bio-Rad Laboratories, Inc. CONTACT: Christine Tsingos,
Vice President and Chief Financial Officer, or Ron Hutton,
Treasurer, +1-510-724-7000, or , both of Bio-Rad Laboratories, Inc.
Web site: http://www.bio-rad.com/
Copyright